Bumper Offer - Urjas oil Just @ Rs. 1
Ziblok, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Angina, High BP. Ziblok also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Ziblok. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Ziblok are Blurred vision, Cold hands. Apart from the aforementioned side effects, Ziblok can also lead to other problems, which have been listed below. Usually, these side effects of Ziblok go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Ziblok is Severe for pregnant women and Severe for women who are breastfeeding. It is important to know if Ziblok has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Ziblok related warnings section.
Ziblok is contraindicated in people with pre-existing medical conditions like Diabetes, Low Blood Pressure (Hypotension), Asthma as it can result in adverse effects. Other conditions have been mentioned below in the Ziblok contraindications section.
Besides this, Ziblok may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Ziblok is not safe while driving, and is is not addictive in nature.
Ziblok is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Ziblok is used -
Moderate
Mild
Common
Is the use of Ziblok safe for pregnant women?
Pregnant women may get severe side effects after taking Ziblok. If you are pregnant, do not take Ziblok without a doctor's advice.
Is the use of Ziblok safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Ziblok. So it is adviced to consult the doctor before using it.
What is the effect of Ziblok on the Kidneys?
Very few cases of side effects of Ziblok on kidney have been reported.
What is the effect of Ziblok on the Liver?
Information about safety of Ziblok for the liver is not available since scientific research on this is yet to be done.
What is the effect of Ziblok on the Heart?
Very few cases of side effects of Ziblok on the heart have been reported.
Ziblok should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ziblok unless your doctor advises you to do so -
Is this Ziblok habit forming or addictive?
Ziblok is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Ziblok as you may feel sleepy.
Is it safe?
Yes, but consume Ziblok only on doctor's advice.
Is it able to treat mental disorders?
Ziblok is unable to treat or cure mental disorders.
Interaction between Food and Ziblok
Ziblok may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Ziblok
Taking Ziblok with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198